Three years ago, a small, little-talked-about report was released by the Department of the Interior.
It was written by a bureau of the department known as the U.S. Geological Survey.
The goal of the report was simple: identify information on events, trends, and issues for each mineral commodity. After all, the non-fuel minerals they researched were vital to the U.S. economy.
The value added to our GDP by the industries consuming them was close to $3 trillion.
Their findings were both profound and devastating.
Now, President Trump has a chance to right that ship.
And it’s providing us with a chance to tack a few extra zeros onto the end of our profits.
Trump’s Resource War Against China
In that USGS report, researchers found that the United States heavily relied on foreign countries for a host of strategic minerals.
“How bad is it,” you ask?
Well, let me show you.
Here’s the list, taken straight out of that 2017 report:
In fact, we rely on foreign imports for approximately 70% of 40 strategic minerals.
And as you can probably guess, many of those involve rare earth and battery metals.
Our analysts have traveled the world over, dedicated to finding the best and most profitable investments in the global energy markets. All you have to do to join our Energy and Capital investment community is sign up for the daily newsletter below.
Take another look at that list, and you can see that we’re dependent on China for most of them:
That’s a problem.
For one of those strategic minerals, the situation is even more dire.
Hailed as a “miracle metal” by auto and tech giants alike, it’s one of the most contested metals on the planet right now.
It’s so important that it’s led Congress to introduce H.R. 520.
Under this bill, projects that would develop our supply of these strategic minerals would be fast-tracked.
There’s one major issue: Nobody is mining it right now in the U.S.
But that’s about to change…
Invest Ahead of the Bloody Curve
The cold, hard truth is that blood has been spilling openly in streets for this “miracle metal” lately.
And, we don’t need the ghost of Baron Rothschild to know our next move.
Put all of the pieces together, and you can see the win-win situation lining up right now for investors.
Every projection out there has demand going through the roof over the next decade.
Here’s the dirty little secret…
Not only is demand projected to double over the next five years thanks to the rapid transition toward electric vehicles that the world’s largest automakers are trying to make, but it’s a vital component for the biggest tech companies on the planet.
This “miracle metal” is everywhere.
If you’re reading this on your phone, you’re holding a bit of it right now.
Of course, the investment herd is conveniently forgetting that without it, every one of those companies — from Tesla to Apple — would be bankrupt.
Yes, it’s THAT important to them.
Getting it, however, isn’t so simple.
That’s why Elon Musk recently got a jump on his competition and is trying to secure his very own personal supply of it as you read this.
He knows that not a single Model 3 will roll off the assembly line without it.
What makes this situation even more dire is that there hasn’t been a single primary mine inside the United States that extracts this “miracle metal”…
Tomorrow morning, I’m going to show you the one stock that’s about to break this door wide open for investors.
Until next time,
A true insider in the technology and energy markets, Keith’s research has helped everyday investors capitalize from the rapid adoption of new technology trends and energy transitions. Keith connects with hundreds of thousands of readers as the Managing Editor of Energy & Capital, as well as the investment director of Angel Publishing’s Energy Investor and Technology and Opportunity.
For nearly two decades, Keith has been providing in-depth coverage of the hottest investment trends before they go mainstream — from the shale oil and gas boom in the United States to the red-hot EV revolution currently underway. Keith and his readers have banked hundreds of winning trades on the 5G rollout and on key advancements in robotics and AI technology.
Keith’s keen trading acumen and investment research also extend all the way into the complex biotech sector, where he and his readers take advantage of the newest and most groundbreaking medical therapies being developed by nearly 1,000 biotech companies. His network includes hundreds of experts, from M.D.s and Ph.D.s to lab scientists grinding out the latest medical technology and treatments. You can join his vast investment community and target the most profitable biotech stocks in Keith’s Topline Trader advisory newsletter.